ERBB2 and breast carcinoma: Huck and collaborators proved that lack of beta1 integrin expression in ErbB2-positive breast cancer cells impairs proliferation, blood vessel formation and decreases lung metastasis by inhibiting Src, FAK, p130CAS and Paxillin phosphorylation [30].